Nalmefene for reducing alcohol consumption in people with alcohol dependence: evaluation report
01 - Pre-Meeting Briefing prepared by NICE
02 - Submission from the technology manufacturer – Lundbeck UK
03 - NICE request to the manufacturer for clarification on their submission
04 - Manufacturer clarification response
05 – Additional manufacturer clarification response
06 - Consultee submission – ADFAM
07 - Consultee submission – Alcohol Concern
08 - Consultee submission – Royal College of Nursing
09 – Clinical expert personal perspective – Daly
10 – Clinical expert personal perspective – Greasley
11 – Patient expert personal perspective – Langford
12 – Patient expert personal perspective – Standing
13 - Evidence Review Group report prepared by the School of Health and Related Research (ScHARR)
14 - Manufacturer factual accuracy check of Evidence Review Group report
Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.
It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.
If you have any feedback on the new format please contact the Project Manager for this appraisal.
Nalmefene for reducing alcohol consumption in people with alcohol dependence: evaluation report
09 July 2014 (9.55 Mb 29 sec) |
This page was last updated: 13 March 2015